Ameriprise
CO

Ameriprise’s Global Cord Blood Corporation CO Stock Holding History

Ameriprise’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-220,928
Closed -$2.1M – 3852
2018
Q2 		$2.1M Sell
220,928
-128,127
-37% -$1.23M ﹤0.01% 2716
2018
Q1 		$3.56M Hold
349,055
– – ﹤0.01% 2416
2017
Q4 		$3.47M Hold
349,055
– – ﹤0.01% 2365
2017
Q3 		$3.88M Buy
+349,055
New +$4.09M ﹤0.01% 2261

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
SAM
Silphium Asset Management London, United Kingdom $297M AUM 28.02% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise's CO Position: Q3 2018 in Review

Ameriprise sold out of Global Cord Blood Corporation (CO) in Q3 2018, closing a stake of 220,928 shares — an estimated $2.1M sold.

Ameriprise first reported a position in CO in Q3 2017 and held it in 4 quarters. The position peaked at $3.88M in Q3 2017. 43 funds tracked by Wall St. Rank hold CO as of Q3 2018.

  • Ameriprise reported no remaining Global Cord Blood Corporation position as of Q3 2018 after selling out during the quarter.
  • Ameriprise sold 220,928 Global Cord Blood Corporation shares in Q3 2018, an estimated $2.1M.
  • Ameriprise first reported a position in Global Cord Blood Corporation in Q3 2017 and held it in 4 quarters.
  • Ameriprise's Global Cord Blood Corporation position peaked at $3.88M in Q3 2017.
  • 43 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2018.

Based on Ameriprise's 13F filing for Q3 2018, filed 14 Nov 2018.